Genmab — Marts 2021
-
Der er selvfølgelig den ledelsesmæssige signalværdi i tilbagekøbsprogrammet, da Genmab jo ikke betaler udbytte. Men tilbagkøb bør jo så måske være en strategi fremover, for at sikre en stabil aktør i markedet. Dog tænker jeg, det er vigtigt at der ikke tilbagkøbes til en for høj pris, for så reagerer markedet. Men ikke uening i, at de 200.000 nok er i forhold til optionerne, da beløbet ikke er større.
-
Tilbagekøbet af op til 200.000 aktier sker som afdækning af warrants https://ir.genmab.com/static-files/8c119d3f-8300-4424-976a-55ead9bf4838 Det vil sige, at aktierne ikke bliver annuleret som ved et "normalt" tilbagekøb, hvor ejerandelen bliver øget for de resterende aktier.
-
funny how even Takeda uses Dara for a combination trial with their TAK-981 instead of their own CD38 loser https://clinicaltrials.gov/ct2/show/NCT04776018?term=genmab+OR+daratumumab+OR+darzalex+OR+ofatumumab+OR+Teprotumumab+OR+Tisotumab+OR+camidanlumab+OR+Enapotamab+OR+ADCT-301+OR+duobody+OR+hexabody+OR+Teclistamab+OR+Amivantamab+OR+Talquetamab+OR+Epcoritamab+OR+DuoHexabody&lupd_s=03%2F01%2F2021&draw=2&rank=4
-
small new smoldering trial - DARA RVD For High Risk SMM (PRISM) - https://clinicaltrials.gov/ct2/show/NCT04775550
-
DuoHexaBody-CD37 trial adding more trial centers; wonder if we can get some clinical data as ASCO...
https://clinicaltrials.gov/ct2/history/NCT04358458?A=4&B=5&C=merged#StudyPageTop -
Det er et stykke tid siden, vi har set så civiliseret en lukkeauktion
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind